GlassScriptPhysician profile
Melanie M Hinkle
NPI 1700158508
$1,397.87
in general payments reported to CMS, 2019-2025
24 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.36 · 2022: $273 · 2023: $310 · 2024: $410 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.31 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $212.56 | 2023-2025 | |
| Novo Nordisk INC | $162.87 | 2022-2025 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $95.87 | 2022-2025 | Jynarque |
| Astrazeneca Pharmaceuticals LP | $93.46 | 2023-2025 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $90.40 | 2022-2025 | |
| Irhythm Technologies, INC. | $88.28 | 2023 | Zio Xt Patch |
| Mallinckrodt Hospital Products INC. | $87.79 | 2023-2024 | Acthar, Terlivaz |
| Vifor Pharma, INC. | $68.24 | 2022-2023 | Veltassa, Korsuva |
| E.R. Squibb & Sons, L.L.C. | $58.17 | 2022-2024 | Eliquis, Camzyos |
| Boston Scientific Corporation | $55.12 | 2024-2025 | Watchman Flx |
| Amgen INC. | $49.27 | 2022-2024 | Prolia, Evenity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.93 | 2024-2025 | Lifevest |
| Pfizer INC. | $46.58 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $42.65 | 2021-2022 | |
| Ardelyx, INC. | $33.27 | 2024-2025 | Ibsrela |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $29.87 | 2021-2022 | |
| Abbvie INC. | $21.73 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.35 | 2025 | Entyvio |
| Nestle Healthcare Nutrition INC. | $20.04 | 2023 | |
| Novartis Pharmaceuticals Corporation | $15.35 | 2022 | |
| Lilly USA, LLC | $14.75 | 2024 | Zepbound, Jardiance |
| Ascendis Pharma Endocrinology INC | $14.74 | 2025 | Yorvipath |
| Philips North America LLC | $13.90 | 2025 | Extended Holter |
| Ani Pharmaceuticals, INC. | $13.68 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Hinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.